Skip to main content

Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.

Publication ,  Journal Article
Borowitz, MJ; Pullen, DJ; Winick, N; Martin, PL; Bowman, WP; Camitta, B
Published in: Cytometry B Clin Cytom
November 2005

BACKGROUND: Flow cytometric analysis of minimal residual disease (MRD) depends on detecting phenotypically abnormal populations. However, little is known about how phenotypic shifts between diagnosis and relapse affect MRD detection in childhood acute lymphoid leukemia (ALL). METHODS: We compared diagnostic and relapse bone marrow specimens in 42 children with precursor B-ALL studied with the two-tube panel CD19-APC/CD45-PerCP/CD10-PE/CD20-FITC and CD19-APC/CD45-PerCP/CD9-PE/CD34-FITC. RESULTS: At least 29 cases had phenotypic shifts of intensity or coefficient of variation of distribution of one or more markers. Shifts were complex and could not be explained by change in maturation stage. In the majority of cases MRD populations more closely resembled the diagnostic than the relapse specimen. In 6 of 7 MRD negative cases we did not identify an abnormal population that resembled diagnosis or relapse. In the remaining case, in which CD34 and CD10 were lost between diagnosis and relapse, it is possible that we could have missed an MRD population resembling relapse. CONCLUSIONS: Phenotypic shifts are common, but do not affect MRD recognition. At most 1 of 42 cases might have harbored an abnormal population undetected because of shift. However, MRD analysis with rigid gating (looking strictly for abnormal phenotypes at diagnosis) might have missed many positive cases, 8 of 22 (36%) in this series.

Duke Scholars

Published In

Cytometry B Clin Cytom

DOI

ISSN

1552-4949

Publication Date

November 2005

Volume

68

Issue

1

Start / End Page

18 / 24

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sensitivity and Specificity
  • Recurrence
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Phenotype
  • Neoplasm, Residual
  • Medical Oncology
  • Immunology
  • Humans
  • Follow-Up Studies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Borowitz, M. J., Pullen, D. J., Winick, N., Martin, P. L., Bowman, W. P., & Camitta, B. (2005). Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group. Cytometry B Clin Cytom, 68(1), 18–24. https://doi.org/10.1002/cyto.b.20071
Borowitz, Michael J., D Jeanette Pullen, Naomi Winick, Paul L. Martin, W Paul Bowman, and Bruce Camitta. “Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.Cytometry B Clin Cytom 68, no. 1 (November 2005): 18–24. https://doi.org/10.1002/cyto.b.20071.
Borowitz, Michael J., et al. “Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.Cytometry B Clin Cytom, vol. 68, no. 1, Nov. 2005, pp. 18–24. Pubmed, doi:10.1002/cyto.b.20071.

Published In

Cytometry B Clin Cytom

DOI

ISSN

1552-4949

Publication Date

November 2005

Volume

68

Issue

1

Start / End Page

18 / 24

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Sensitivity and Specificity
  • Recurrence
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Phenotype
  • Neoplasm, Residual
  • Medical Oncology
  • Immunology
  • Humans
  • Follow-Up Studies